BioVersys AG Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Millions CHF. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Cash & Equivalents	82.51	26.62	24.38
Short-Term Investments	-	6	4
Cash & Short-Term Investments	82.51	32.62	28.38
Cash Growth	152.94%	14.95%	-
Other Receivables	2.44	1.29	2.07
Receivables	2.44	1.29	2.07
Prepaid Expenses	4.93	0.49	0.3
Other Current Assets	-	-	2.85
Total Current Assets	89.87	34.4	33.59
Property, Plant & Equipment	0.77	0.56	0.58
Total Assets	90.64	34.96	34.17
Accounts Payable	2.47	0.71	1.29
Accrued Expenses	2.87	3.45	2.2
Current Portion of Long-Term Debt	0.03	2.98	0.03
Current Portion of Leases	0.26	0.22	0.22
Current Unearned Revenue	2.19	1.15	1.07
Other Current Liabilities	1.08	1.17	4.55
Total Current Liabilities	8.9	9.67	9.37
Long-Term Debt	21.28	13.63	15.55
Long-Term Leases	0.16	0.13	0.13
Pension & Post-Retirement Benefits	0.49	0.84	0.55
Total Liabilities	30.83	24.27	25.59
Common Stock	5.85	3.69	3.06
Additional Paid-In Capital	155.6	87.4	68.77
Retained Earnings	-101.13	-80.34	-62.94
Comprehensive Income & Other	-0.51	-0.07	-0.32
Shareholders' Equity	59.81	10.68	8.58
Total Liabilities & Equity	90.64	34.96	34.17
Total Debt	21.73	16.97	15.93
Net Cash (Debt)	60.78	15.65	12.45
Net Cash Growth	288.25%	25.77%	-
Net Cash Per Share	10.82	4.70	4.17
Filing Date Shares Outstanding	5.85	5.82	2.99
Total Common Shares Outstanding	5.85	0.33	2.99
Working Capital	80.98	24.73	24.22
Book Value Per Share	10.23	32.50	2.87
Tangible Book Value	59.81	10.68	8.58
Tangible Book Value Per Share	10.23	32.50	2.87
Machinery	0.73	0.58	0.54

Source: S&P Global Market Intelligence. Standard template. Financial Sources.